Lance Hill in PharmExec: a bright future for medical affairs
Within3’s CEO shares how technology offers a tech-enabled way forward.
Within3 in European Pharmaceutical Manufacturer: looking back, forging ahead
Our experts weigh in on more trends and predictions for 2023.
Within3 in Journal of mHealth: bridge the insight gap
Within3 CEO Lance Hill explores how better insights can help medical affairs teams gain strategic ground.
Within3 in Authority Magazine: how to take your company from good to great
Authority Magazine interviews Within3 CEO Lance Hill on leadership, business strategy and the path to success.
Within3 in International Clinical Trials: AI-driven data can bolster patient centricity
Within3’s Jason Smith contributes to International Clinical Trials with an article discussing artificial intelligence, clinical trials, and patient centricity.
Within3 in AIthority
Natural language processing and social listening are transforming various aspects of modern business operations – and life science is no exception.
Within3 in Journal of mHealth: operational excellence in medical affairs
The time is right for medical affairs to address vulnerabilities in existing operating models and invest in technologies that strengthen the organization.
Lance Hill on the Pharmaceutical Commerce podcast
Life science companies should look at a modern, tech-enabled process for gathering insight.
Within3 in Journal of mHealth: how can pharma address gender inequality in healthcare?
Life science companies can use technology to correct drug development and healthcare inequalities.
Within3 in The Medicine Maker: insights management for R&D gains
Adopting solutions that provide human-centric knowledge will be the key to increasing the value generated from the pharmaceutical industry’s tech investment.
